NO20012544L - Substituted benzo [de] isoquinoline-1,3-dione - Google Patents

Substituted benzo [de] isoquinoline-1,3-dione

Info

Publication number
NO20012544L
NO20012544L NO20012544A NO20012544A NO20012544L NO 20012544 L NO20012544 L NO 20012544L NO 20012544 A NO20012544 A NO 20012544A NO 20012544 A NO20012544 A NO 20012544A NO 20012544 L NO20012544 L NO 20012544L
Authority
NO
Norway
Prior art keywords
isoquinoline
dione
substituted benzo
benzo
substituted
Prior art date
Application number
NO20012544A
Other languages
Norwegian (no)
Other versions
NO20012544D0 (en
Inventor
Werner Mederski
Ralf Devant
Gerhard Barnickel
Sabine Bernotat-Danielowski
Guido Melzer
Peter Raddatz
Zhengdong Wu
Daljit Dhanoa
Richard M Soll
James Rinker
Todd L Graybill
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20012544D0 publication Critical patent/NO20012544D0/en
Publication of NO20012544L publication Critical patent/NO20012544L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye forbindelser med formel I hvor R, R1 og R2 har de angitte betydninger, og deres salter solvater, som glykoprotein lb antagonister.Novel compounds of formula I wherein R, R 1 and R 2 have the indicated meanings and their salts solvates, as glycoprotein 1b antagonists.

NO20012544A 1998-11-25 2001-05-23 Substituted benzo [de] isoquinoline-1,3-dione NO20012544L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19941398A 1998-11-25 1998-11-25
US39878399A 1999-09-20 1999-09-20
PCT/EP1999/008561 WO2000032577A2 (en) 1998-11-25 1999-11-09 Substituted benzo[de]isoquinoline-1,3-diones

Publications (2)

Publication Number Publication Date
NO20012544D0 NO20012544D0 (en) 2001-05-23
NO20012544L true NO20012544L (en) 2001-05-23

Family

ID=26894745

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012544A NO20012544L (en) 1998-11-25 2001-05-23 Substituted benzo [de] isoquinoline-1,3-dione

Country Status (15)

Country Link
EP (1) EP1144381A2 (en)
JP (1) JP2002537225A (en)
KR (1) KR20010080569A (en)
CN (1) CN1330638A (en)
AU (1) AU760136B2 (en)
BR (1) BR9915648A (en)
CA (1) CA2352045A1 (en)
CZ (1) CZ20011782A3 (en)
HU (1) HUP0104520A3 (en)
ID (1) ID28982A (en)
NO (1) NO20012544L (en)
PL (1) PL348204A1 (en)
SK (1) SK7022001A3 (en)
TW (1) TW473474B (en)
WO (1) WO2000032577A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007421A1 (en) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Medicinal composition
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
EP1402890B1 (en) * 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
US8097725B2 (en) 2004-12-03 2012-01-17 Roche Diagnostics Operations, Inc. Luminescent indicator dye and optical sensor
FR2915685A1 (en) * 2007-05-02 2008-11-07 Thales Sa New fluorescent compounds of solid state in water, with naphthalimide base, useful for allowing the grafting on transducer, which is a biological substance, in biosensor and security or explosive detectors, and as markers
WO2014149198A1 (en) * 2013-03-15 2014-09-25 Alumend, Llc Compositions and methods of using the compositions for plaque softening
CN107417616A (en) 2013-05-01 2017-12-01 中央研究院 Treat the method and composition of beta Thalassemia and drepanocytosis
CN103450176B (en) * 2013-08-15 2016-07-06 大连理工大学 One class is containing 2-(4-aminophenyl) benzothiazole naphthalimide compound and application thereof
WO2016041511A1 (en) 2014-09-19 2016-03-24 Yen-Ta Lu Benzo-heterocyclic compounds and their applications
CN106905237B (en) * 2017-02-08 2019-05-14 上海师范大学 A kind of pH and weary oxygen double-bang firecracker answer the naphthalimide ratio fluorescent probe and its synthetic method of positioning tumor cell
CN110283123B (en) * 2019-07-08 2022-06-17 桂林医学院 4-p-toluenesulfonyl piperazine-3-nitro-1, 8-naphthalimide derivative and synthesis method and application thereof
CN110272388B (en) * 2019-07-08 2022-06-17 桂林医学院 4-dithioformic acid piperazine-3-nitro-1, 8-naphthalimide derivative and synthesis method and application thereof
CN110407865B (en) * 2019-08-02 2022-04-15 山东师范大学 Benzene sulfonamide structure-based compound shown as formula (I) and preparation method and application thereof
CN111518075B (en) * 2020-04-17 2023-03-28 西南大学 Naphthalimide piperazine triazole compound and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2423546C2 (en) * 1974-05-15 1983-01-27 Hoechst Ag, 6000 Frankfurt Process for the preparation of 4-amino-1,8-naphthalic acid-N-arylimide compounds
ES459497A1 (en) * 1977-06-04 1978-04-16 Made Labor Sa N(Aminoalkyl)-naphthalimides and their derivatives
DE3635711A1 (en) * 1986-10-21 1988-04-28 Knoll Ag 5-NITROBENZO (DE) ISOCHINOLIN-1,3-DIONE, THEIR PRODUCTION AND USE
BR9712424A (en) * 1996-10-21 2001-11-20 Allelix Biopharma Deneurotrophin antagonist pharmaceutical composition
AU4946697A (en) * 1996-10-28 1998-05-22 Merck Patent Gmbh Dihydrobenzoanthracenone, -pyrimidinone or dihydronaphtoquinolinone

Also Published As

Publication number Publication date
HUP0104520A2 (en) 2002-04-29
ID28982A (en) 2001-07-19
WO2000032577A3 (en) 2000-09-21
KR20010080569A (en) 2001-08-22
NO20012544D0 (en) 2001-05-23
CN1330638A (en) 2002-01-09
PL348204A1 (en) 2002-05-06
WO2000032577A2 (en) 2000-06-08
JP2002537225A (en) 2002-11-05
CZ20011782A3 (en) 2001-09-12
CA2352045A1 (en) 2000-06-08
BR9915648A (en) 2001-08-14
SK7022001A3 (en) 2002-09-10
TW473474B (en) 2002-01-21
EP1144381A2 (en) 2001-10-17
AU2660300A (en) 2000-06-19
AU760136B2 (en) 2003-05-08
HUP0104520A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
NO20012544L (en) Substituted benzo [de] isoquinoline-1,3-dione
NO992821L (en) Ketobenzamides as Calpain Inhibitors
PT923554E (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
NO974236L (en) Disubstituted 1,4-piperidine esters and amides having 5-HT 4 antagonistic activity
ES2072096T3 (en) 4-PHENYLPIPERIDINES N-SUBSTITUTED OPIOID ANTAGONISTS.
NO20006282L (en) New cyclosporins
DE69903333T2 (en) CRF RECEPTOR ANTAGONISTS AND RELATED METHODS
AU9281198A (en) Benzofuran derivatives
TR200403436T2 (en) Crystalline 1-methylcarbapenem derivatives.
NO953052L (en) New pyrrolocarbazoles
NO20012543L (en) Substituted benzo [de] isoquinoline-1,3-dione
DE69919436D1 (en) N-acyl and N-aroyl aralkylamides
NO20021503L (en) quinazolinones
DE60034577D1 (en) IN 4-POSITION SUBSTITUTED PIPERIDINE DERIVATIVES
DE60006825D1 (en) SEROTONERGE BENZOFURANE
FI905957A (en) FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE CYKLOHEXENER, SOM VERKAR PAO DET CENTRALA NERVSYSTEMET.
ATE521610T1 (en) SPIR COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
NO20021502L (en) quinazolinones
NO20010626L (en) N-substituted azabicycloheptane derivatives, their preparation and use
NO971424L (en) Novel heterocyclic substituted imidazoloquinoxalinones, their preparation and use
NO20020886L (en) Novel integrin <alfa> v <beta> 3 inhibitors
DE69706950D1 (en) Furoindolizine
NZ335631A (en) Antipsychotic (neuroleptic) piperidine derivatives
NO20004075L (en) Substituted pyrimidin-2-yloxy-carboxylic acid derivatives, their preparation and their use as endothelin antagonists
NO20002154L (en) Novel heterocyclic substituted alpha hydroxycarboxylic acid derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application